3-(2-Methyl-1-imidazolyl)-3-phenyl-1-(3H)isobenzofuranones
    1.
    发明授权
    3-(2-Methyl-1-imidazolyl)-3-phenyl-1-(3H)isobenzofuranones 失效
    3-(2-甲基-1-咪唑基)-3-苯基-1-(3H)异苯并呋喃酮

    公开(公告)号:US3927018A

    公开(公告)日:1975-12-16

    申请号:US53543874

    申请日:1974-12-23

    申请人: SANDOZ AG

    IPC分类号: C07D521/00 C07D405/04

    摘要: Substituted isobenzofuranones, e.g., 3-(2-methyl-1-imidazolyl)3-phenyl-1-(3H)isobenzofuranone, are prepared by reacting a corresponding substituted 2-benzoylbenzoyl chloride with a 2methylimidazole and are useful as antiinflammatory agents.

    摘要翻译: 通过使相应的取代的2-苯甲酰基苯甲酰氯与2-甲基咪唑反应制备取代的异苯并呋喃酮,例如3-(2-甲基-1-咪唑基)-3-苯基-1-(3H)异苯并呋喃酮,可用作抗炎剂 。

    10-(2-Dialkylaminoethyl)-10,11-dihydro, or 10-(2-dialkylaminoethyl)-5-methylene-2,7-substituted or unsubstituted-5H-dibenzo{8 a,d{9 cycloheptenes
    2.
    发明授权
    10-(2-Dialkylaminoethyl)-10,11-dihydro, or 10-(2-dialkylaminoethyl)-5-methylene-2,7-substituted or unsubstituted-5H-dibenzo{8 a,d{9 cycloheptenes 失效
    10-(2-二烷基氨基乙基)-10,11-二氢或10-(2-二烷基氨基乙基)-5-亚甲基-2,7-取代或未取代的-5H-二苯并{8α,d {9环庚烯

    公开(公告)号:US3925476A

    公开(公告)日:1975-12-09

    申请号:US22432372

    申请日:1972-02-07

    申请人: SANDOZ AG

    IPC分类号: C07C229/38 C07C87/29

    CPC分类号: C07C229/38

    摘要: 10-(2-dialkylaminoethyl)-10,11-dihydro, or 10-(2dialkylaminoethyl)-5-methylene-2,7-substituted or unsubstituted5H-dibenzo(a,d)cyclo-heptenes e.g. 10-(2-dimethylaminoethyl)10,11-dihydro-5-methylene-5H -dibenzo(a,d)cycloheptene, prepared by acid dehydration the corresponding dibenzo(a,d)cycloheptene-5ols. The compounds are useful as anti-depressants.

    摘要翻译: 10-(2-二烷基氨基乙基)-10,11-二氢或10-(2-二烷基氨基乙基)-5-亚甲基-2,7-取代或未取代的-5H-二苯并[a,d]环庚烯。 通过酸性脱水相应的二苯并[a,d]环庚烯-5-醇制备10-(2-二甲基氨基乙基)-10,11-二氢-5-亚甲基-5H-二苯并[a,d]环洛芬。 该化合物可用作抗抑郁剂。

    Spiro dibenzocycloheptene isoindoline
    5.
    发明授权
    Spiro dibenzocycloheptene isoindoline 失效
    SPIRO DIBENZOCYCLOHEPTENE ISOINDOLINE

    公开(公告)号:US3868390A

    公开(公告)日:1975-02-25

    申请号:US32507673

    申请日:1973-01-19

    申请人: SANDOZ AG

    IPC分类号: C07D209/96 C07D27/48

    摘要: Spiro(10,11-dihydro-5H-dibenzo(a,d)cycloheptene-5,1''-N-methyl isoindoline) may be prepared by treating a corresponding isoindolinone with mild reducing agent. The compound is useful as an analgesic.

    摘要翻译: 螺[10,11-二氢-5H-二苯并[a,d]环庚烯-5,1'-N-甲基异吲哚啉]可以通过用温和还原剂处理相应的异吲哚啉酮来制备。 该化合物可用作镇痛药。

    Lithiated n-benzyl benzamides
    6.
    发明授权
    Lithiated n-benzyl benzamides 失效
    LITHIATED N-BENZYL BENZAMIDES

    公开(公告)号:US3860649A

    公开(公告)日:1975-01-14

    申请号:US39943073

    申请日:1973-09-21

    申请人: SANDOZ AG

    IPC分类号: C07F1/02 C07C119/00

    CPC分类号: C07F1/02

    摘要: Substituted benzyl-10,11-dihydro and corresponding 10,11unsaturated dibenzocycloheptenols, e.g., 5-(a-amino benzyl)10,11-dihydro-5H-dibenzo(a,d)cyclohepten-5-ol, useful as diuretics, prepared from a series of reactions starting with a dibenzo-cycloheptenone and lithiated N-benzyl benzamides.

    摘要翻译: 取代的苄基-10,11-二氢和相应的10,11-不饱和二苯并环庚烯醇,例如5-(α-氨基苄基)-10,11-二氢-5H-二苯并[a,d]环庚烯-5-醇,其可用作 利尿剂,由二苯并环庚烯酮和锂化N-苄基苯甲酰胺开始的一系列反应制备。

    2,3,5,6-TETRAHYDROIMIDAZO{8 2,1-b{9 THIAZOLES
    8.
    发明授权
    2,3,5,6-TETRAHYDROIMIDAZO{8 2,1-b{9 THIAZOLES 失效
    2,3,5,6-四氢吡啶并[{2,1-b {9 thiazoles

    公开(公告)号:US3671533A

    公开(公告)日:1972-06-20

    申请号:US3671533D

    申请日:1970-01-26

    申请人: SANDOZ AG

    IPC分类号: C07D513/04 C07D99/06

    CPC分类号: C07D513/04 Y10S514/91

    摘要: Substituted imidazo thiazoles, e.g., 3-(4''-chlorophenyl)-2ethyl-3-hydroxy-2,3,5,6-tetrahydroimidazo(2,1-b) thiazole are prepared from 2-haloalkylphenones and 2-imidazolinethione and are useful as anorexics and anti-depressants.

    摘要翻译: 取代的咪唑并噻唑,例如3-(4'-氯苯基)-2-乙基-3-羟基-2,3,5,6-四氢咪唑并[2,1-b]噻唑由2-卤代烷基苯酮和2-咪唑啉硫酮制备 并且作为厌食症和抗抑郁剂是有用的。

    Isoindolo(1 2-a)isoquinolines
    10.
    发明授权
    Isoindolo(1 2-a)isoquinolines 失效
    ISOINDOLO(1 2-A)ISOQUINOLINES

    公开(公告)号:US3644370A

    公开(公告)日:1972-02-22

    申请号:US3644370D

    申请日:1969-11-17

    申请人: SANDOZ AG

    CPC分类号: C07D209/48 C07D471/04

    摘要: THE COMPOUNDS AND CERTAIN INTERMEDIATES ARE USEFUL AS CENTRAL NERVOUS SYSTEM STIMULANTS AND ANTI-INFLAMMATORIES. THEY ARE PREPARED BY CONVERTING AN ISOINDOLO(1,2-A)ISOQUINOLINE TO ITS QUATERNARY AMMONIUM SALT BY TREATMENT WITH A LOWER ALKYL HALIDE, E.G. METHYL IODIDE, AND REDUCING THE SALT BY SODIUM IN LIQUID AMMONIA TO CLEAVE THE BOND COMMON TO THE FIVE MEMBERED RING OF THE ISOINDOLO MOIETY AND SIX MEMBERED RING TO THE ISOQUINOLINO MOIETY, THUS FORMING THE NINE MEMBERED N-HETEROCYCLIC RING OF DIBENZ(C,F)AZONINE. FOR EXAMPLE, 2,3-CIMETHOXY-7-METHYL5,6,7,8-TETRAHYDRODIBENZ(C,F)AZONINE CAN THUS BE PREPARED FROM 2,3-DIMETHOXY-5,6,8,12B-TETRAHYDROISOINDOLO(1,2-A)ISOQUINOLINE.